<?xml version='1.0' encoding='utf-8'?>
<document id="26053962"><sentence text="Evaluation of CYP3A-mediated drug-drug interactions with romidepsin in patients with advanced cancer."><entity charOffset="57-67" id="DDI-PubMed.26053962.s1.e0" text="romidepsin" /></sentence><sentence text="Two multicenter, single-arm, single-infusion, open-label studies were conducted to evaluate the effect of ketoconazole (a strong CYP3A inhibitor) or rifampin (a strong CYP3A inducer) daily for 5 days on the pharmacokinetics (PK) and safety of romidepsin (8 mg/m(2) intravenous 4-hour infusion for the ketoconazole study or a 14 mg/m(2) intravenous 4-hour infusion for the rifampin study) in patients with advanced cancer"><entity charOffset="106-118" id="DDI-PubMed.26053962.s2.e0" text="ketoconazole" /><entity charOffset="149-157" id="DDI-PubMed.26053962.s2.e1" text="rifampin" /><entity charOffset="243-253" id="DDI-PubMed.26053962.s2.e2" text="romidepsin" /><entity charOffset="301-313" id="DDI-PubMed.26053962.s2.e3" text="ketoconazole" /><entity charOffset="372-380" id="DDI-PubMed.26053962.s2.e4" text="rifampin" /><pair ddi="false" e1="DDI-PubMed.26053962.s2.e0" e2="DDI-PubMed.26053962.s2.e0" /><pair ddi="false" e1="DDI-PubMed.26053962.s2.e0" e2="DDI-PubMed.26053962.s2.e1" /><pair ddi="false" e1="DDI-PubMed.26053962.s2.e0" e2="DDI-PubMed.26053962.s2.e2" /><pair ddi="false" e1="DDI-PubMed.26053962.s2.e0" e2="DDI-PubMed.26053962.s2.e3" /><pair ddi="false" e1="DDI-PubMed.26053962.s2.e0" e2="DDI-PubMed.26053962.s2.e4" /><pair ddi="false" e1="DDI-PubMed.26053962.s2.e1" e2="DDI-PubMed.26053962.s2.e1" /><pair ddi="false" e1="DDI-PubMed.26053962.s2.e1" e2="DDI-PubMed.26053962.s2.e2" /><pair ddi="false" e1="DDI-PubMed.26053962.s2.e1" e2="DDI-PubMed.26053962.s2.e3" /><pair ddi="false" e1="DDI-PubMed.26053962.s2.e1" e2="DDI-PubMed.26053962.s2.e4" /><pair ddi="false" e1="DDI-PubMed.26053962.s2.e2" e2="DDI-PubMed.26053962.s2.e2" /><pair ddi="false" e1="DDI-PubMed.26053962.s2.e2" e2="DDI-PubMed.26053962.s2.e3" /><pair ddi="false" e1="DDI-PubMed.26053962.s2.e2" e2="DDI-PubMed.26053962.s2.e4" /><pair ddi="false" e1="DDI-PubMed.26053962.s2.e3" e2="DDI-PubMed.26053962.s2.e3" /><pair ddi="false" e1="DDI-PubMed.26053962.s2.e3" e2="DDI-PubMed.26053962.s2.e4" /></sentence><sentence text=" Romidepsin coadministered with ketoconazole (400 mg) or rifampin (600 mg) was not bioequivalent to romidepsin alone"><entity charOffset="32-44" id="DDI-PubMed.26053962.s3.e0" text="ketoconazole" /><entity charOffset="57-65" id="DDI-PubMed.26053962.s3.e1" text="rifampin" /><entity charOffset="100-110" id="DDI-PubMed.26053962.s3.e2" text="romidepsin" /><pair ddi="false" e1="DDI-PubMed.26053962.s3.e0" e2="DDI-PubMed.26053962.s3.e0" /><pair ddi="false" e1="DDI-PubMed.26053962.s3.e0" e2="DDI-PubMed.26053962.s3.e1" /><pair ddi="false" e1="DDI-PubMed.26053962.s3.e0" e2="DDI-PubMed.26053962.s3.e2" /><pair ddi="false" e1="DDI-PubMed.26053962.s3.e1" e2="DDI-PubMed.26053962.s3.e1" /><pair ddi="false" e1="DDI-PubMed.26053962.s3.e1" e2="DDI-PubMed.26053962.s3.e2" /></sentence><sentence text=" With ketoconazole, the mean romidepsin AUC and Cmax were increased by approximately 25% and 10%, respectively"><entity charOffset="6-18" id="DDI-PubMed.26053962.s4.e0" text="ketoconazole" /></sentence><sentence text=" With rifampin, the mean romidepsin AUC and Cmax were unexpectedly increased by approximately 80% and 60%, respectively; this is likely because of inhibition of active liver uptake"><entity charOffset="6-14" id="DDI-PubMed.26053962.s5.e0" text="rifampin" /></sentence><sentence text=" For both studies, romidepsin clearance and volume of distribution were decreased, terminal half-life was comparable, and median Tmax was similar" /><sentence text=" Overall, the safety profile of romidepsin was not altered by coadministration with ketoconazole or rifampin, except that a higher incidence and greater severity of thrombocytopenia was observed when romidepsin was given with rifampin"><entity charOffset="32-42" id="DDI-PubMed.26053962.s7.e0" text="romidepsin" /><entity charOffset="84-96" id="DDI-PubMed.26053962.s7.e1" text="ketoconazole" /><entity charOffset="100-108" id="DDI-PubMed.26053962.s7.e2" text="rifampin" /><entity charOffset="200-210" id="DDI-PubMed.26053962.s7.e3" text="romidepsin" /><entity charOffset="226-234" id="DDI-PubMed.26053962.s7.e4" text="rifampin" /><pair ddi="false" e1="DDI-PubMed.26053962.s7.e0" e2="DDI-PubMed.26053962.s7.e0" /><pair ddi="false" e1="DDI-PubMed.26053962.s7.e0" e2="DDI-PubMed.26053962.s7.e1" /><pair ddi="false" e1="DDI-PubMed.26053962.s7.e0" e2="DDI-PubMed.26053962.s7.e2" /><pair ddi="false" e1="DDI-PubMed.26053962.s7.e0" e2="DDI-PubMed.26053962.s7.e3" /><pair ddi="false" e1="DDI-PubMed.26053962.s7.e0" e2="DDI-PubMed.26053962.s7.e4" /><pair ddi="false" e1="DDI-PubMed.26053962.s7.e1" e2="DDI-PubMed.26053962.s7.e1" /><pair ddi="false" e1="DDI-PubMed.26053962.s7.e1" e2="DDI-PubMed.26053962.s7.e2" /><pair ddi="false" e1="DDI-PubMed.26053962.s7.e1" e2="DDI-PubMed.26053962.s7.e3" /><pair ddi="false" e1="DDI-PubMed.26053962.s7.e1" e2="DDI-PubMed.26053962.s7.e4" /><pair ddi="false" e1="DDI-PubMed.26053962.s7.e2" e2="DDI-PubMed.26053962.s7.e2" /><pair ddi="false" e1="DDI-PubMed.26053962.s7.e2" e2="DDI-PubMed.26053962.s7.e3" /><pair ddi="false" e1="DDI-PubMed.26053962.s7.e2" e2="DDI-PubMed.26053962.s7.e4" /><pair ddi="false" e1="DDI-PubMed.26053962.s7.e3" e2="DDI-PubMed.26053962.s7.e3" /><pair ddi="false" e1="DDI-PubMed.26053962.s7.e3" e2="DDI-PubMed.26053962.s7.e4" /></sentence><sentence text=" The use of romidepsin with rifampin and strong CYP3A inducers should be avoided"><entity charOffset="12-22" id="DDI-PubMed.26053962.s8.e0" text="romidepsin" /><entity charOffset="28-36" id="DDI-PubMed.26053962.s8.e1" text="rifampin" /><pair ddi="false" e1="DDI-PubMed.26053962.s8.e0" e2="DDI-PubMed.26053962.s8.e0" /><pair ddi="false" e1="DDI-PubMed.26053962.s8.e0" e2="DDI-PubMed.26053962.s8.e1" /></sentence><sentence text=" Toxicity related to romidepsin exposure should be monitored when romidepsin is given with strong CYP3A inhibitors"><entity charOffset="21-31" id="DDI-PubMed.26053962.s9.e0" text="romidepsin" /><entity charOffset="66-76" id="DDI-PubMed.26053962.s9.e1" text="romidepsin" /><pair ddi="false" e1="DDI-PubMed.26053962.s9.e0" e2="DDI-PubMed.26053962.s9.e0" /><pair ddi="false" e1="DDI-PubMed.26053962.s9.e0" e2="DDI-PubMed.26053962.s9.e1" /></sentence><sentence text="" /></document>